 Cellular Biomedicine Group Inc. NASDAQ: CBMG CBMG or the Company, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today presented a poster during the 2020 American Association for Cancer Research AACR annual meeting to be held as a virtual meeting from June 22-24, 2020. 